ࡱ >
\ p None B a = c @ = Z ?N*8 X" 1 Arial1 Arial1 Arial1 Arial1 Arial1 Arial1 Arial General ` Table 1 [ Characteristics All (n = 296) DM (n = 140) Non-DM (n = 156) p First ABI year 0.002 2009 or before 177 69 108 2 0 1 0 2 0 1 5 119 71 48 Age at first ABI (year) 58.0 11.8
60.8 9.1 55.6 13.4 < 0.001 Male gender (%) 51.0 54.3 48.1 0.286 Duration of dialysis (years)
2 . 5 ( 0 . 8 7 . 0 )
1 . 3 ( 0 . 6 4 . 4 )
5 . 1 ( 1 . 3 9 . 2 ) Smoking history (%) 33.4 41.7 26.3 0.005 Hypertension (%) 71.2 80.0 63.5 Coronary artery disease (%) 18.9 22.9 15.4 0.101 Cerebrovascular disease (%) 7.8 13.6 2.6 Systolic blood pressure (mmHg) 151.6 25.9 160.2 25.4 143.9 23.9 Diastolic blood pressure (mmHg) 80.7 14.5 82.0 14.0 79.6 14.9 0.154 Pulse pressure (mmHg) 71.0 17.6 78.5 17.8 64.3 14.5 Laboratory parameters Albumin (g/dL) 3.9 0.3 4.0 0.3 0.001 Triglyceride (mg/dL) 1 2 5 . 5 ( 8 9 . 3 1 9 2 )
1 4 0 ( 1 0 4 2 0 8 ) 1 1 9 ( 8 3 1 8 1 ) 0.006 Total cholesterol (mg/dL) 178.4 42.2 182.5 49.2 174.8 34.5 0.135 HDL-cholesterol (mg/dL) 40.3 11.3 38.0 10.0 42.5 12.0 LDL-cholesterol (mg/dL) 89.2 31.3 91.8 36.2 86.8 26.0 0.182 Hemoglobin (g/dL)
10.1 1.3
10.2 1.2
10.0 1.3 0.426 Creatinine (mg/dL)
10.2 2.4 9.5 2.7
10.7 2.5 Total calcium (mg/dL) 9.3 0.9 9.2 0.8 9.4 0.9 0.054 Phosphorous (mg/dL) 4.9 1.3 4.8 1.4 0.620; Calcium-phosphorous product (mg2/dL2) 45.2 12.7 45.1 12.1 45.4 13.2 0.840 Uric acid (mg/dL) 7.8 1.6 7.7 1.6 0.572 PTH (pg/mL) 3 1 2 . 6 ( 1 6 0 . 7 5 3 2 . 7 ) 2 6 0 . 8 ( 1 5 0 . 5 4 2 1 . 6 ) 3 5 1 . 2 ( 1 7 3 . 6 6 3 3 . 2 ) 0.011 Kt/V (Daugirdas) 1.5 0.3 1.6 0.3 0.035 Medications Aspirin use (%) 8.1 10.0 6.4 0.259 ACEI and/or ARB use (%) 16.2 21.4 11.5 0.021 Statin use (%) 16.6 12.2 0.033
ABI < 0.9 (%) 21.0 30.9 Death (%) 19.0 22.5 15.9 0.153
d MbP?_ % " * + &P &F